COMMUNIQUÉS West-GlobeNewswire

TRU NIAGEN® to be Featured at the American Academy of Anti-Aging Medicine Annual Meeting

12/12/2018 - 12:30

Dr. Charles Brenner to deliver scientific presentation and “Father of Biohacking” Dave Asprey to sign copies of his new book, Game Changers LOS ANGELES, Dec. 12, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) [...]

MediciNova to Present at the J.P. Morgan Healthcare Conference in San Francisco

12/12/2018 - 12:00

LA JOLLA, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

Rule 2.9 Announcement

12/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 12 December 2018 [...]

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018

12/12/2018 - 07:31

Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of [...]

DBV Technologies communique des données à l'appui de l'induction de l'immunotolérance par la peau au Inflammatory Skin Disease Summit 2018

12/12/2018 - 07:31

Montrouge, France, le 12 décembre (07h30 CET), 2018 DBV Technologies communique des données à l'appui de l'induction de l'immunotolérance par la peau au Inflammatory Skin Disease Summit 2018 Une étude unique en son [...]

Santhera Announces Financial Results for the First Nine Months of 2018

12/12/2018 - 07:29

Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and confirms its guidance and positive outlook. Santhera is on [...]

Santhera Launches Placement of Shares through Accelerated Bookbuilding

12/12/2018 - 07:26

Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5,000,000 registered shares with a nominal value of CHF 1 each to [...]

Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock

12/12/2018 - 07:01

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an underwritten public [...]

DiaMedica Closes Public Offering in the United States

11/12/2018 - 23:30

MINNEAPOLIS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“ DiaMedica ” or the “ Company ”) (NASDAQ:DMAC; TSXV:DMA), a clinical stage biopharmaceutical company, announced today that it has completed an [...]

Intra-Cellular Therapies Announces Favorable Results From Long-Term Open-Label Safety Switching Study With Lumateperone in Patients with Schizophrenia at the 57th Annual Meeting of the American College of Neuropsychopharmacology

11/12/2018 - 23:30

Favorable safety results following administration of lumateperone for up to one year treatment duration are consistent with and extend the safety and tolerability profile previously reported in short-term trials Intra- [...]

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/12/2018 - 23:07

MENLO PARK, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Healthcare Special Opportunities Fund Announces December 2018 Quarterly Distribution

11/12/2018 - 23:00

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- (TSX:MDS.UN) – LDIC Inc. (the “Manager”), the manager of Healthcare Special Opportunities [...]

Quotient Limited Announces Receipt of the ISO 13485:2016 Certification of its State of the Art MosaiQ™ Microarray Manufacturing Facility

11/12/2018 - 22:30

JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported receipt of the formal ISO 13485:2016 certification for its [...]

Management Cease Trade Order Update

11/12/2018 - 22:15

HALIFAX, Nova Scotia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]

Help Your Diabetes® Added To Franchise Dictionary’s Top 100 Game Changers As “One To Watch”

11/12/2018 - 22:11

GRAPEVINE, Texas, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Today, Help Your Diabetes®, a company that helps Type 2 Diabetics live diabetes-free lives through natural methods, announced that they have been voted into the Top [...]

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

11/12/2018 - 22:10

FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems Information Technologies, Inc [...]

Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency

11/12/2018 - 22:05

Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data Anticipated in Q1 2021 Company to Host Conference Call Today at 5:00 p.m. ET [...]

Viveve Announces Closing of Public Offering of Shares of Common Stock

11/12/2018 - 22:05

ENGLEWOOD, Colo., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the closing of its previously [...]

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares

11/12/2018 - 22:05

JERSEY, Channel Islands, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the closing of its previously announced underwritten [...]